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of users, who, when the devices initially arrive at the 
place of intended use, struggle with an important task 
of correctly identifying and registering these devices in 
their local databases. This means that there are a number 
of players, having quite different responsibilities and 
levels of understanding of the processes, but all with one 
common interest, that of ensuring the availability of sound 
medical devices to the general public. To assist in this very 
important process there is a need for a common method 
INTRODUCTION
Within all regulations concerned with medical devices, 
there are a number of obligations placed upon the 
manufacturer. In addition, the authorities are faced with 
the task of regulating the manufacturers and their devices, 
and there are the people involved in the trade of these 
devices (e.g., the suppliers), before the devices themselves 
are brought into use. Finally, of course, there is the myriad 
Quality Assurance
Global Medical Device Nomenclature: The Concept for Reducing 
Device-Related Medical Errors
Anand K, Saini SK1, Singh BK2, Veermaram C
Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Jodhpur National University, 
Jodhpur, Rajasthan, 1Medical Affairs, Johnson and Johnson Limited, Gurgaon, Haryana, 2Department of 
Pharmaceutical Sciences, Kumaun University, Nainital, Uttarakhand, India
Address for correspondence: Kaushik Anand; E-mail: bkaushikp@gmail.com
ABSTRACT
In the medical device field, there are a number of players, having quite different responsibilities and levels of 
understanding of the processes, but all with one common interest, that of ensuring the availability of sound 
medical devices to the general public. To assist in this very important process, there is a need for a common 
method for describing and identifying these medical devices in an unambiguous manner. The Global Medical 
Device Nomenclature (GMDN) now provides, for the first time, an international tool for identifying all medical 
devices, at the generic level, in a meaningful manner that can be understood by all users. Prior to the GMDN, 
many nomenclature systems existed, all built upon different structures, and used locally or nationally for special 
purposes, with unusual approaches. These diverse systems, although often workable in their own right, have had 
no impact on improving the overall situation of providing a common platform, whereby, medical devices could 
be correctly identified and the related data safely exchanged between the involved parties. Work by standard 
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Standardization), from 1993 to 1996, resulted in a standard that specified a structure for a new nomenclature, 
for medical devices. In this article we are trying to explain GMDN as the prime method to reduce medical device 
errors, and to understand the concept of GMDN, to regulate the medical device throughout the globe. Here we 
also make an attempt to explain various aspects of the GMDN system, such as, the process of development 
of the GMDN-CEN report, purpose, benefits, and their structural considerations. In addition, there will be an 
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for describing and identifying these medical devices in an 
unambiguous manner. The GMDN now provides, for the 
first time, an international tool for identifying all medical 
devices at the generic level, in a meaningful manner, which 
can be understood by all users.
Prior to the GMDN, many nomenclature systems existed, 
all built upon different structures, and used locally 
or nationally for diverse purposes and with unusual 
approaches. These diverse systems were CNMD, EDMA, 
ISO 9999, JFMDA, NKKN, UMDNS, and so on, and 
furthermore these were used to develop global medical 
device nomenclature systems. Although often workable 
in their own right, they had no impact on improving the 
overall situation of providing a common platform whereby 
medical devices could be correctly identified and the related 
data safely exchanged between the involved parties. The 
advent of the European directives, initiated a new era, 
where national and indeed international bodies were given 
the opportunity to cooperate and harmonize their efforts 
in achieving the one thing that they all needed, namely, a 
standardized method of identifying the products placed 
in the global market.
Work by standard organizations like CEN and ISO, 
from 1993 to 1996, resulted in a standard that specified 
a structure for a new nomenclature for medical devices. 
This standard, now revised by ISO, is published as the 
ISO 15225 Nomenclature – Medical device nomenclature 
data structure. Following this, a project was set up in 1997, 
by the CEN, with financial support from the European 
Commission (EC). The aim of the project was to create 
a comprehensive nomenclature for all medical devices, 
suitable for use by all interested parties globally.[1] 
To facilitate the rapid production of the GMDN, six 
existing nomenclatures of particular standing were 
adopted. These covered a wide range of terms defining 
medical devices and healthcare products that combined, 
gave a total of 13,500 terms.
The six chosen nomenclatures were:
•  Classification Names for Medical Devices (CNMD) and 
in vitro Diagnostic Products. Developed by the Food 
and Drug Administration (FDA), USA.
•  European Diagnostic Manufacturers Association 
(EDMA) in vitro diagnostic product classification. Used 
in Europe.
•  ISO 9999 Technical Aids for Disabled Persons 
Classification. International use.
•  Japanese Medical Device Nomenclature (JFMDA). 
Used in Japan.
•  Norsk Klassifisering Koding and Nomenklatur 
(NKKN), Norwegian Nomenclature.
•  Universal Medical Device Nomenclature System 
(UMDNS). Developed by ECRI, USA.
On the 1st November, 2001, the Global Medical Device 
Nomenclature (GMDN) was published as a CEN Report 
CR 14230 and as ISO.TS 20225. The first public release 
on CD-ROM as GMDN version 2002.1 was in November 
2002.[1]
Development of GMDN-CEN Report CR 14230 
Medical  Device  experts  from  around  the  world 
(manufacturers, healthcare authorities, and regulators) 
compiled the initial GMDN nomenclature based on the 
standard ISO 15225. The study was mandated by the 
European Commission in order to provide the necessary 
tool to carry out many of the obligations following the 
implementation of the Medical Devices Directives, and 
also, to meet similar needs at the Global level, as identified 
in the Global harmonization activities of GHTF by its 
members, notably USA (FDA), Canada, European member 
states, Japan, Australia, and now by many other countries 
/ regions.[2]
In 1991, the first international workshop on harmonization 
of Medical Devices Nomenclature was held among EU, 
EFTA, Canada, and USA. However, there was no fruitful 
outcome of this meeting. Consequently in 1993, as 
requested by the Commission, CEN established a standard 
to define a structural basis for a device nomenclature. 
Subsequently symbols, coding, and proposed nomenclature 
were developed by USA workgroups in 1994 and 1995; there 
was a CEN recommendation for an interim nomenclature 
system.[3] Adding to these, in 1996, a project proposal 
for a device nomenclature system was submitted and it 
was positively accepted by the European nomenclature 
standard, through the Vienna agreement.[2] All this resulted 
in one single harmonized standard. There was also a license 
agreement between ECRI and CEN for the use of their 
UMDNS (Universal Medical Device Nomenclature System) 
as one component of the development process. From 1997 
to 1999, the GMDN Project was undertaken, based on the 
structural standard. It defined the general structure of the 
nomenclature and provided the required understanding 
of field lengths, data relationships, and so on. The project 
involved some 70 medical device experts from 16 countries, 
a Project Council of 10 members, an Expert Advisory 
team of six members, and a secretarial / support team of 
six members. Finally in 2001, the GMDN Nomenclature 
as the CEN Technical Report CR 14230, was released, GMDN: The concept for reducing device related medical errors
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which was identical to the ISO Technical Specification 
ISO TS 20225.[2] There was also the establishment of the 
GMDN Maintenance Agency Policy Group, which was 
responsible for the future management of the GMDN 
as also to develop and distribute the electronic version of 
the GMDN and all future versions of the data file. BSI 
(British Standards Institution) as delegated by CEN has 
recognized the GMDN Agency to be the formal body for 
the ongoing management and control of the GMDN on a 
global basis. The GMDN Agency has therefore exercised, 
and will continue to exercise, the sole rights to develop and 
distribute all versions of the GMDN and its associated 
data, terminology, and supporting databases.[3]
Purpose of global medical device nomenclature
The foremost purpose of the GMDN is to provide a 
single, global, nomenclature system by which the authorities 
can regulate medical devices; this is also impacting upon 
the healthcare providers, who are the mainstay users of 
medical devices, the medical device manufactures, suppliers, 
conformity assessment bodies, and other affiliated parties, 
so that there is only one single system that provides generic 
product descriptors to support patient safety.[1] The GMDN 
code represents the generic descriptor (this being the term 
name along with its definition) in order to internationally 
standardize device identification, for reasons of safe data 
exchange between competent authorities and others, 
exchange of post-market vigilance information, research, 
medical record keeping, e-commerce, and inventory 
purposes.[4]
Benefits of global medical device nomenclature
Internationally, it provides a common terminology, enabling 
global regulatory partners to efficiently communicate and 
share medical device details. If we talk about the national 
benefits, it provides a common terminology, enabling the 
federal entities and the industry to efficiently communicate 
and share medical device data. DHHS promotes the work 
on the GMDN and consolidates with UMDNS, which 
anticipates a federal government standard in a few years. 
As far as the Regulatory agency is concerned, the GMDN 
provides guidelines for the appropriate and consistent 
naming of the device groups and the creation of descriptive 
definitions that are device-group specific. Specifically, their 
utilization by regulators will help to improve nomenclature 
practices, cross-generational consistency, and data 
management, for post-market activities.[4]
Global medical device nomenclature structure
The general structure of the GMDN is regulated by 
requirements stipulated in the standard ISO 15225 
Nomenclature – Medical device nomenclature data 
structure. Figure 1 shows the basic organization of the 
GMDN data. The data is defined by three levels, associated 
with an external fourth level, each level containing data that 
differs in the degree of specificity.[5] 
Device category
The device category is the broadest level of the GMDN 
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data. It divides the entire medical device product market 
into the highest-level groups based on device application, 
technology, or other common characteristics. The standard 
allocates codes for possibly 20 categories; there are 
currently 16 established device categories.[6] These are:
Code  Term
01  Active implantable devices
02  Anesthetic and respiratory devices
03  Dental devices
04  Electromechanical medical devices
05  Hospital hardware
06  In vitro diagnostic devices
07  Non-active implantable devices
08  Ophthalmic and optical devices
09  Reusable devices
10  Single use devices
11  Assistive products for persons with disability
12  Diagnostic and therapeutic radiation devices
13  Complementary therapy devices
14  Biological-derived devices
15  Healthcare facility products and adaptations
16  Laboratory equipment
17  Reserved




The generic device group is the most specific level at which 
products are aggregated, based on common technology or 
intended use. There are four different types of GMDN 
terms associated with the generic device groups. These 
terms, with their alpha identifiers, include the:
Preferred term      P
Template term      T
Synonym term      S
Multiple-linked synonym term  MS
There are also terms within the main database called 
‘Equivalent terms’. These are simply nonactive terms from 
the original six source nomenclatures used to develop the 
GMDN and can be equal to a P, T, S, or MS term within 
the database. They are identified with the alpha identifier E.
Using the GMDN search engine, or using some of the view 
possibilities provided by the database, E terms can be found 
and viewed. The GMDN user is not to be concerned with 
equivalent terms, as they are not active terms, they have no 
GMDN code allocated, and cannot be used by a user for 
any practical application.
Preferred terms
Preferred terms with their unique five-digit codes are 
the only terms available for product identification. The 
preferred term is the optimal name selected to represent a 
group of devices (a collection of device types) that have the 
same or similar intended use or commonality of technology 
allowing them to be grouped in a generic manner, typically 
without reflecting the specialized characteristics, such as, 
brand or trade names. 
Each preferred term has an associated definition that 
describes the most prominent characteristic of the device 
types in the group [typically includes a physical description 
and an intended use(s)]. It is the definition that determines 
the scope of the preferred term and code. The preferred 
term type identifier is (P).
Template terms
The template term is a general device name added to the 
nomenclature when multiple preferred terms have identical 
character strings forming a base concept, and functions 
as a header term to create a simple hierarchy for lexically-
related preferred terms.
Each template term has an associated definition that 
is inclusive of all subordinated preferred terms. The 
template term type identifier is (T). The template term is 
a navigational tool only and must not be used for product 
identification purposes.
If a template term code has been used to identify any 
products in the past, this code has been wrongly applied and 
is not valid. A GMDN P term and code that is applicable 
to the product must be selected and assigned instead. If no 
current GMDN P terms are applicable, an application for 
the creation of a new term or modification of an existing 
P term must be submitted.[5]
Synonym terms
The synonym term is the common use or a familiar name 
used in the nomenclature. It is an alternative entry point 
in the nomenclature, used to locate the preferred term 
or template term to which it is linked. It may or may 
not actually be synonymous with the term to which it is 
linked. The synonym term type identifier is (S). Selecting 
a synonym term in the GMDN database will automatically 
produce its linked preferred or template term. The 
synonym term is a navigational tool only and must not be 
used for product identification purposes.GMDN: The concept for reducing device related medical errors
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Multiple-linked synonym term
The multiple-linked synonym term is a medical device name, 
often from one of the GMDN source nomenclatures, that 
is typically of a higher-order, and is therefore linked to 
more than one preferred term and / or template term. The 
multiple-linked synonym term type identifier is (MS). This 
multiple-linked synonym term is a navigational tool only 
and must not be used for product identification purposes.
Collective terms
Collective terms are used to aggregate medical device 
groups that have common features and are identified in 
the GMDN. Although the GMDN has been designed and 
developed for regulatory data exchange in areas such as 
vigilance reporting and tracking of medical device safety, 
there is a need for a set of terms that are more refined than 
the GMDN category terms, yet broader than the GMDN 
generic device group terms, to be used in the application 
of the medical device directives; the use of collective terms 
satisfies this requirement.[5]
Collective terms are intended to be used for a whole range 
of subject matters, for example:
•  To illustrate the scope of certificates issued by Notified 
Bodies when assessing which groups, families or types 
of medical devices are covered within a manufacturer’s 
quality system
•  To be used to identify the range of skills and general 
technological abilities for which a Notified Body has 
been approved, and is so appointed by the relevant 
Competent Authority
•  For exchanges of information between Competent 
Authorities when general information on individual 
manufacturers capabilities is notified for inclusion in the 
European Database for Medical Devices (EUDAMED)
There were several means identified to aggregate the 
generic device group terms of the GMDN using collective 
terms. These were:
•  Devices covered by the application of common 
technology
•  Devices manufactured using similar manufacturing 
procedures and common technical features
•  Devices manufactured for the application of similar 
Medical Procedures
•  Devices manufactured using common materials 
requiring special skills
•  Devices developed to meet specific risk-associated 
considerations
For the ease of electronic transmission of data and code 
recognition, each collective term is assigned a four-digit 
incremental code, with the prefix ‘CT’ (Collective Term).
Coding system for GMDN
All terms in the GMDN are assigned a unique code. This 
provides security in cases of misunderstandings, language 
barriers, or discrepancies in the data systems. The code is 
an incremental, sequential cardinal number comprising of 
five digits starting from 10000. The codes in themselves 
are not created with an integral hierarchical structure and 
are simply unique numbers. The codes are the carriers of 
the information to which they are linked and should always 
be used and referred to in any reference to the GMDN or 
data transaction. There are only three categories of ranges 
that are used in the coding system for GMDN.[2]
They are:
a.  Codes in the range of 1 – 9999
b.  Codes in the range of 10000 – 30000
c.  Codes above the range of 30000
Codes in the range of 1 – 9999 are not represented in the 
GMDN. These, as stated in the standard, are exclusively 
reserved for assignment by any end user and may be used 
as desired in any user’s local data system. It is important 
for readers to understand that this range of codes should 
not be used for any kind of official purpose, for example, 
as temporary codes, as national translated synonyms, or 
where the data is exchanged between users outside of the 
local data system. This will lead to ambiguity.
Codes in the range of 10000 – 30000 are represented in 
the GMDN and have been reserved exclusively to represent 
the original code used by the ECRI organization for their 
UMDNS terms that have been adopted for use in the 
GMDN. This will provide the GMDN user with automatic 
mapping from the ECRI code representing the UMDNS 
term to the identical GMDN code used at present to 
represent the GMDN term. This has been done to assist 
in the transition for users who have previously used the 
ECRI UMDNS.
Codes above the range of 30000 are all GMDN, created 
for GMDN terms.[2]
Role of GMDN agency/governance
The need for a Maintenance Agency was identified and 
the structure was approved within the CEN. Therefore, in 
order to manage the GMDN, a maintenance agency was Anand, et al. J Young Pharm. 2010;2(4): 403-409
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set up to form the necessary legal entity. This non-profit 
company, the GMDN Agency, acting as the Maintenance 
Agency Secretariat (MAS), functioned as the hub in the 
running and maintenance of the GMDN. It also provided 
services and information for access to the GMDN data 
through the Internet site or other means. To ensure 
continuing permanency of the GMDN, revenues could be 
generated through the licensing or sale of GMDN Agency 
products and services, or by direct funding, allocated by 
relevant global regulatory bodies or other parties.[5]
Services provided by the GMDN agency are:
•  Access to the GMDN data file and codes using the 
Internet site through a license agreement and / or by 
direct credit card purchase
•  A link from the GMDN database to the user’s in-house 
data system through a license agreement and a custom-
made software link
•  Application form for new terms or modification of 
existing terms / definitions for the identification of 
the user’s product
•  Access to GMDN terminology and information
•  Guidance on how to use the GMDN
•  Access to Collective terms
•  GMDN translational software tools 
A Maintenance Agency Policy Group (MAPG), now an 
entity of the GMDN Agency, ensures a globally recognized 
representation that consists of delegates from authorities 
and the industry, as well as other interested parties. Based 
on the original Technical Report a vastly developed and 
enhanced GMDN is now available through the GMDN 
Agency. 
The main role of the GMDN Agency is in accordance with 
its Memorandum of Association as follows:[5]
•  To carry out the functions of a Maintenance Agency 
to develop and maintain the ‘Global Medical Device 
Nomenclature’ for medical devices
•  To meet the needs identified by the European 
Commission when developing the European Directives 
on Medical Devices, to establish a nomenclature for 
medical device generic descriptors that will meet a global 
need for identification purposes. This identification 
will facilitate exchange of regulatory data and assist in 
the identification of medical devices for commercial 
purposes
•  To ensure that the GMDN meets the needs of all 
national authorities, the industry, and other users 
globally, as the primary reference and working generic 
nomenclature for the exchange of regulatory and 
commercial information
•  To ensure that the GMDN is constructed with reference 
to European and International standards, indicating the 
structure of such a medical device nomenclature (e.g., 
EN ISO 15225)
•  To be responsible for adding, amending, and archiving 
terms and definitions for medical devices and to assign 
codes as required, to provide easy identification. Such 
codes will be consistent so that all translated versions 
of the nomenclature will carry an identical code for 
each generic or other term as specified in the GMDN 
•  To liaise with standards bodies (e.g., CEN, CENELEC, 
ISO, IEC), to be aware of the current standards 
on medical device nomenclature (including any 
additional levels of identification, e.g., collective terms, 
identification of particular attributes, and links to other 
nomenclatures as appropriate)
•  To coordinate and link with appropriate organizations 
for the translation of GMDN into other languages 
Utilization of GMDN in unique device identification 
For the sake of patient safety, in the era of global economy, 
it is desirable to address tracking and tracing of medical 
devices at a global level. One reliable way to achieve 
the track and trace of medical devices is to develop a 
Unique Device Identifier (UDI). The primary aim of a 
UDI mechanism is to increase patient safety. It will also 
improve the work of market surveillance authorities in 
case of field safety corrective actions, for instance, the 
fight against counterfeiting. In addition, the development 
of an international approach will make the trade of 
medical devices more secure for all the stakeholders (health 
authorities, hospitals, manufacturers, distributors, etc.).[4]
This is why the introduction of GMDN in a UDI system 
appears to many regional regulatory authorities and to the 
industry at large, as an effective tool to protect public health 
more efficiently. It is mainly for reasons of patient safety 
that all the actors of the sector advice development of 
UDI for medical devices. Therefore, common worldwide 
UDI requirements would offer significant benefits to the 
manufacturer, user and / or patient, and the Regulatory 
Authorities. In addition, eliminating or reducing differences 
between jurisdictions decreases the cost of gaining 
regulatory compliance. Second, while developing a UDI 
system, one important consideration which should be taken 
into account is the risk associated with the device. The UDI 
mechanism should be implemented stepwise according to 
the risk of the device — starting with the highest risk first 
(e.g., implants) and staggering the implementation, with 
the lowest risk class (e.g., most disposables) implemented GMDN: The concept for reducing device related medical errors
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last. Furthermore, the introduction of the UDI should 
allow sufficient implementation timeframes, to allow the 
manufacturers to comply with the requirements. Finally, 
in order to achieve all the positive elements of a UDI 
mechanism, the use of the UDI should be promoted 
among all stakeholders, including regulatory agencies, 
medical device manufacturers, distributors, hospitals, and 
medical professionals.
A UDI for medical devices will consist of a unique 
identification code using a globally accepted standard 
format like the GMDN. In order to accommodate most 
methods of labeling, marking, and identifying products, 
the UDI should be technology neutral, that is, it should 
not be restricted to a particular method of Automatic 
Identification and Data Capture (AIDC).[4] The UDI 
database shall allow the use of an existing globally accepted 
data exchange process to harmonize the exchange of device 
information, for safety purposes. It should utilize a globally 
accepted nomenclature such as the Global Medical Device 
Nomenclature (GMDN).
Current areas of focus with a vision for the future
•  There should be a continued efforts to consolidate 
UMDNS and GMDN
•  Continue to prepare for harmonized regulatory 
utilization of GMDN by developing requirements for 
the integration of GMDN data into device registration 
as well as approval applications
•  We should continue working on the system for the 
unique identification of products, to potentially be 
associated with the GMDN
•  In future a high-quality medical device terminology 
should be the standard that promotes good data 
management, which should be associated with unique 
device identification[4]
SUMMARY
Global Medical Device Nomenclature is an internationally 
recognized system of names, definitions, and codes used 
to accurately identify and discretely describe generic 
medical device groups primarily for product certification 
/ registration, vigilance reporting, and product recall. The 
foremost purpose of the GMDN is to provide a single, 
global, nomenclature system, by which the authorities can 
regulate medical devices; this is also impacting upon the 
healthcare providers, who are the mainstay users of medical 
devices, the medical device manufacturers, suppliers, 
conformity assessment bodies, and other affiliated parties, 
so that there is only one single system that provides the 
generic product descriptors, to support patient safety. 
Specifically, their utilization by all stakeholders will help 
to improve nomenclature practices, cross-generational 
consistency, and data management, for post-market 
activities. To summarize, we can say that after adopting 
the GMDN concept there may be, 
•  Common terminology for efficient data sharing and 
communication
•  Improved nomenclature practices and device group 
identification
•  Potential for a system of unique device identification 
that links device-group information with device-type 
information
•  Essentially there will be improved data management for 
post-market activities, which will reduce medical device 
errors
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